Company profile
Edinburgh Molecular Imaging Limited
Emimaging - Edinburgh Molecular Imaging | Edinburgh Molecular Imaging | See. Treat. Cure.
Edinburgh Molecular Imaging Limited is a UK company with status active founded in 2014 based in Scotland.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
SME that is focussing on Optical Molecular Imaging and the rapid commercialisation of in vivo optical imaging agents for human disease
Project impact
Raised £4M Series A. Awarded Innovate UK award.
Public funding
Projects
Novel c-Met Protein Targeted Molecular Imaging of Cancer with the SurgVision Endoscope Explorer
1 Dec 2017 to 30 Nov 2019
To deliver a revolutionary optical cancer screening solution that combines a unique biomarker with a novel imaging device, addressing a significant gap associated with current screening methods (high cancer miss rates, poor visualisation). Project outputs will determine which of a number of possible indications to take forward to full stage clinical trial...
Enhanced in-vivo screening and molecular analysis for colorectal cancer
1 Mar 2016 to 30 Nov 2016
Abstract: Colorectal Cancer (CRC), also known as bowel cancer, is the third most common cancer diagnosed in men and second most common cancer in women, affecting 1,361,000 people worldwide each year. It is also the second most common cause of cancer related deaths, contributing to 737,000 deaths every year (Globocan, 2012). CRC is a slow growing tumour th...